243 related articles for article (PubMed ID: 36672216)
1. Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
Ludewig S; Salzburger L; Goihl A; Rohne J; Leypoldt F; Bittner D; Düzel E; Schraven B; Reinhold D; Korte M; Körtvélyessy P
Cells; 2023 Jan; 12(2):. PubMed ID: 36672216
[TBL] [Abstract][Full Text] [Related]
2. LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.
Petit-Pedrol M; Sell J; Planagumà J; Mannara F; Radosevic M; Haselmann H; Ceanga M; Sabater L; Spatola M; Soto D; Gasull X; Dalmau J; Geis C
Brain; 2018 Nov; 141(11):3144-3159. PubMed ID: 30346486
[TBL] [Abstract][Full Text] [Related]
3. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
[TBL] [Abstract][Full Text] [Related]
4. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
5. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
6. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
[TBL] [Abstract][Full Text] [Related]
7. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
8. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
9. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H
Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438
[TBL] [Abstract][Full Text] [Related]
11. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
Ramberger M; Berretta A; Tan JMM; Sun B; Michael S; Yeo T; Theorell J; Bashford-Rogers R; Paneva S; O'Dowd V; Dedi N; Topia S; Griffin R; Ramirez-Franco J; El Far O; Baulac S; Leite MI; Sen A; Jeans A; McMillan D; Marshall D; Anthony D; Lightwood D; Waters P; Irani SR
Brain; 2020 Jun; 143(6):1731-1745. PubMed ID: 32437528
[TBL] [Abstract][Full Text] [Related]
12. The Treatment and Follow-Up of Anti-LGI1 Limbic Encephalitis.
Yu J; Yu X; Fang S; Zhang Y; Lin W
Eur Neurol; 2016; 75(1-2):5-11. PubMed ID: 26694143
[TBL] [Abstract][Full Text] [Related]
13. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors.
Ohkawa T; Fukata Y; Yamasaki M; Miyazaki T; Yokoi N; Takashima H; Watanabe M; Watanabe O; Fukata M
J Neurosci; 2013 Nov; 33(46):18161-74. PubMed ID: 24227725
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
16. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
Malter MP; Frisch C; Schoene-Bake JC; Helmstaedter C; Wandinger KP; Stoecker W; Urbach H; Surges R; Elger CE; Vincent AV; Bien CG
J Neurol; 2014 Sep; 261(9):1695-705. PubMed ID: 24935858
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
[TBL] [Abstract][Full Text] [Related]
18. A feline model of spontaneously occurring autoimmune limbic encephalitis.
Glantschnigg-Eisl U; Klang A; Kneissl S; Lang B; Waters P; Irani SR; Binks SNM; Pakozdy A
Vet J; 2023; 296-297():105974. PubMed ID: 36958405
[TBL] [Abstract][Full Text] [Related]
19. An Unusual Case of LGI1 (Leucine-Rich Glioma-Inactivated Protein 1) Limbic Encephalitis With Anti-acetylcholine Receptor and Anti-striational Autoantibodies.
Pathak A; Patel J; Tran G; Mrlik M; Zhong N; Lui F
Cureus; 2023 Oct; 15(10):e46491. PubMed ID: 37927656
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
